These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31799433)

  • 1. Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands.
    Belorusova AY; Evertsson E; Hovdal D; Sandmark J; Bratt E; Maxvall I; Schulman IG; Åkerblad P; Lindstedt EL
    Commun Biol; 2019; 2():431. PubMed ID: 31799433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs).
    Slominski AT; Kim TK; Qayyum S; Song Y; Janjetovic Z; Oak ASW; Slominski RM; Raman C; Stefan J; Mier-Aguilar CA; Atigadda V; Crossman DK; Golub A; Bilokin Y; Tang EKY; Chen JY; Tuckey RC; Jetten AM; Song Y
    Sci Rep; 2021 Apr; 11(1):8002. PubMed ID: 33850196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EEPD1 Is a Novel LXR Target Gene in Macrophages Which Regulates ABCA1 Abundance and Cholesterol Efflux.
    Nelson JK; Koenis DS; Scheij S; Cook EC; Moeton M; Santos A; Lobaccaro JA; Baron S; Zelcer N
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):423-432. PubMed ID: 28082258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.
    Shrestha E; Hussein MA; Savas JN; Ouimet M; Barrett TJ; Leone S; Yates JR; Moore KJ; Fisher EA; Garabedian MJ
    J Biol Chem; 2016 May; 291(21):11172-84. PubMed ID: 27026705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LXRα Regulates ChREBPα Transactivity in a Target Gene-Specific Manner through an Agonist-Modulated LBD-LID Interaction.
    Fan Q; Nørgaard RC; Grytten I; Ness CM; Lucas C; Vekterud K; Soedling H; Matthews J; Lemma RB; Gabrielsen OS; Bindesbøll C; Ulven SM; Nebb HI; Grønning-Wang LM; Sæther T
    Cells; 2020 May; 9(5):. PubMed ID: 32414201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
    Trasino SE; Kim YS; Wang TT
    Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
    Ulven SM; Dalen KT; Gustafsson JA; Nebb HI
    J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
    Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
    Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.
    Li Y; Bolten C; Bhat BG; Woodring-Dietz J; Li S; Prayaga SK; Xia C; Lala DS
    Mol Endocrinol; 2002 Mar; 16(3):506-14. PubMed ID: 11875109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis.
    Lin YN; Chang HY; Wang CCN; Chu FY; Shen HY; Chen CJ; Lim YP
    J Agric Food Chem; 2018 Oct; 66(42):10964-10976. PubMed ID: 30351048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
    Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
    J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying selective agonists targeting LXRβ from terpene compounds of alismatis rhizoma.
    Lin C; Li J; Wu C; Bao J
    J Mol Model; 2021 Feb; 27(3):91. PubMed ID: 33616795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands.
    Yang C; McDonald JG; Patel A; Zhang Y; Umetani M; Xu F; Westover EJ; Covey DF; Mangelsdorf DJ; Cohen JC; Hobbs HH
    J Biol Chem; 2006 Sep; 281(38):27816-26. PubMed ID: 16857673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
    Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
    Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor: a potential target in the treatment of atherosclerosis.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Opin Ther Targets; 2022 Jul; 26(7):645-658. PubMed ID: 36003057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of gene expression by LXRs in response to macrophage cholesterol loading.
    Ignatova ID; Angdisen J; Moran E; Schulman IG
    Mol Endocrinol; 2013 Jul; 27(7):1036-47. PubMed ID: 23686114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C24-hydroxylated stigmastane derivatives as Liver X Receptor agonists.
    Castro Navas FF; Giorgi G; Maggioni D; Pacciarini M; Russo V; Marinozzi M
    Chem Phys Lipids; 2018 May; 212():44-50. PubMed ID: 29352964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.